Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Hybrid polar compounds, of which hexamethylenebisacetamide (HMBA) is the prototype, are potent inducers of differentiation of murine erythroleukemia (MEL) cells and a wide variety of other transformed cells. HMBA has been shown to induce differentiation of neoplastic cells in patients, but is not an...
Tallennettuna:
| Julkaisussa: | Proc Natl Acad Sci U S A |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
National Academy of Sciences
1996
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC39124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8650156/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.12.5705 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
